<DOC>
	<DOCNO>NCT02349516</DOCNO>
	<brief_summary>A randomize , control study safety efficacy Squalamine Lactate Eye Drops combination Ranibizumab intravitreal injection patient diabetic macular edema . The study duration 52 week patient randomize one four treatment arm .</brief_summary>
	<brief_title>Squalamine Lactate Eye Drops Combination With Ranibizumab Patients With Diabetic Macular Edema ( DME )</brief_title>
	<detailed_description>A randomize , control study safety efficacy Squalamine Lactate eye drop combination Ranibizumab intravitreal injection patient diabetic macular edema . Subjects randomize one follow treatment arm : 1 . Squalamine Lactate Ophthalmic Solution administer twice day 52 week combination monthly injection ranibizumab baseline week 20 ranibizumab need week 24 week 52 . 2 . Vehicle Ophthalmic Solution administer twice day 52 week combination monthly injection ranibizumab baseline week 20 ranibizumab need week 24 week 52 . 3 . Squalamine Lactate Ophthalmic Solution administer four time day 52 week combination monthly injection ranibizumab baseline week 20 ranibizumab need week 24 week 52 . 4 . Vehicle Ophthalmic Solution administer four time day 52 week combination monthly injection ranibizumab baseline week 20 ranibizumab need week 24 week 52 .</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<mesh_term>Squalamine</mesh_term>
	<criteria>Subjects clinically significant diabetic macular edema ≥ 300 micron central involvement use Heidelberg Cirrus machine Best correct visual acuity 20/32 20/320 inclusive study eye Adults ≥ 18 year age type 1 2 diabetes mellitus diabetic macular edema History vitreoretinal surgery study eye Panretinal laser photocoagulation macular laser photocoagulation study eye within 3 month screen Any prior laser study eye Previous use intraocular periocular corticosteroid study eye within 6 month screen Previous treatment antiangiogenic drug either eye within 3 month screen Uncontrolled diabetes mellitus HbA1c level great 12 Ocular disorder study eye , diabetic macular edema , confound interpretation study result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>